Abstract:Genome-wide association studies (GWAS) provide valuable insights into the genetic architecture of complex traits, yet interpreting their results remains challenging due to the polygenic nature of most traits. Gene set analysis offers a solution by aggregating genetic variants into biologically relevant pathways, enhancing the detection of coordinated effects across multiple genes. In this study, we present and evaluate a gene set prioritization approach utilizing Bayesian Linear Regression (BLR) models to uncover shared genetic components among different phenotypes and facilitate biological interpretation. Through extensive simulations and analyses of real traits, we demonstrate the efficacy of the BLR model in prioritizing pathways for complex traits. Simulation studies reveal insights into the model’s performance under various scenarios, highlighting the impact of factors such as the number of causal genes, proportions of causal variants, heritability, and disease prevalence. Application of both single-trait and multi-trait BLR models to real data, specifically GWAS summary data for type 2 diabetes (T2D) and related phenotypes, identifies significant associations with T2D-related pathways. Furthermore, comparison between single- and multi-trait BLR analyses highlights the superior performance of the multi-trait approach in identifying associated pathways, showcasing increased statistical power when analyzing multiple traits jointly. Additionally, enrichment analysis with integrated data from various public resources supports our results, confirming significant enrichment of diabetes-related genes within the top T2D pathways resulting from the multi-trait analysis. The BLR model’s ability to handle diverse genomic features, perform regularization, conduct variable selection, and integrate information from multiple traits, genders, and ancestries demonstrates its utility in understanding the genetic architecture of complex traits. Our study provides insights into the potential of the BLR model to prioritize gene sets, offering a flexible framework applicable to various datasets. This model presents opportunities for advancing personalized medicine by exploring the genetic underpinnings of multifactorial traits, potentially leading to tailored therapeutic interventions.

Simplifying causal gene identification in GWAS loci

An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci

Reaching the End-Game for GWAS: Machine Learning Approaches for the Prioritization of Complex Disease Loci

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics

Network Based Approach to Gene Prioritization at Genome-Wide Association Study Loci

Genome-wide interaction-based association analysis identified multiple new susceptibility Loci for common diseases.

Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning

Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics

The Integrated Landscape of Biological Candidate Causal Genes in Coronary Artery Disease

Evaluation of Bayesian Linear Regression Models for Gene Set Prioritization in Complex Diseases

GenePANDA—a Novel Network-Based Gene Prioritizing Tool for Complex Diseases

GPA: A statistical approach to prioritizing GWAS results by integrating pleiotropy information and annotation data

A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits

GPA: A Statistical Approach to Prioritizing GWAS Results by Integrating Pleiotropy and Annotation

Causal inference for multiple risk factors and diseases from genomics data

Gene prioritization in GWAS loci using multimodal evidence

An accurate genetic colocalization method for the HLA locus

A review of post-GWAS prioritization approaches

In search of causal variants: refining disease association signals using cross-population contrasts

Decoding polygenic diseases: advances in noncoding variant prioritization and validation

Genome-wide Causation Studies of Complex Diseases